Advertisement

Contrast-Induced Nephropathy Morbidity and Mortality Following Percutaneous Coronary Intervention

      The recent publication by Jabara et al
      • Jabara R.
      • Gadesam R.R.
      • Pendyala L.K.
      • Knopf W.D.
      • Chronos N.
      • Chen J.P.
      • Viel K.
      • King III, S.B.
      • Manoukian S.V.
      Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention.
      from the Oxilan Registry reported rates of contrast-induced nephropathy (CIN) in a convenience sample of patients who underwent percutaneous coronary intervention and received the contrast medium ioxilan from 2006 to 2007, with 3- to 5-day serum creatinine follow-up. One quarter of the patients (n = 100) in the original cohort were excluded for lack of serum creatinine follow-up, leaving 275 patients in the convenience sample for analysis. The investigators concluded, using several definitions of CIN, that there were no adverse outcomes associated with CIN.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jabara R.
        • Gadesam R.R.
        • Pendyala L.K.
        • Knopf W.D.
        • Chronos N.
        • Chen J.P.
        • Viel K.
        • King III, S.B.
        • Manoukian S.V.
        Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention.
        Am J Cardiol. 2009; 103: 1657-1662
        • Solomon R.
        • Segal A.S.
        Defining acute kidney injury: what is the most appropriate metric?.
        Nature Clin Pract Nephrol. 2008; 4: 208-215
        • Waikar S.S.
        • Bonventre J.V.
        Creatinine kinetics and the definition of acute kidney injury.
        J Am Soc Nephrol. 2009; 20: 672-679
        • Mehta R.L.
        • Kellum J.A.
        • Shah S.V.
        • Molitoris B.A.
        • Ronco C.
        • Warnock D.G.
        • Levin A.
        Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.
        Crit Care. 2007; 11: R31
        • Solomon R.J.
        • Mehran R.
        • Natarajan M.K.
        • Doucet S.
        • Katholi R.E.
        • Staniloae C.S.
        • Sharma S.K.
        • Labinaz M.
        • Gelormini J.L.
        • Barrett B.J.
        Contrast-induced nephropathy and long-term adverse events: cause and effect?.
        Clin J Am Soc Nephrol. 2009; 4: 1162-1169
        • Brown J.R.
        • Malenka D.J.
        • DeVries J.T.
        • Robb J.F.
        • Jayne J.E.
        • Friedman B.J.
        • Hettleman B.D.
        • Niles N.W.
        • Kaplan A.V.
        • Schoolwerth A.C.
        • Thompson C.A.
        Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: insights from the Dartmouth Dynamic Registry.
        Catheter Cardiovasc Interv. 2008; 72: 347-354